Quest Diagnostics, Inc [DGX] stock is trading at $164.18, down -3.78%. An important factor to consider is whether the stock is rising or falling in short-term value. The DGX shares have lost -1.88% over the last week, with a monthly amount drifted -4.36%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on April 02, 2025, when Redburn Atlantic initiated its Buy rating and assigned the stock a price target of $195. Previously, Citigroup downgraded its rating to Neutral on March 04, 2025, and kept the price target unchanged to $185. On January 06, 2025, upgrade upgraded it’s rating to Outperform and revised its price target to $174 on the stock. Morgan Stanley upgraded its rating to a Overweight and increased its price target to $172 on December 17, 2024. Robert W. Baird upgraded its rating to Outperform for this stock on October 23, 2024, and upped its price target to $182.
Quest Diagnostics, Inc [DGX] stock has fluctuated between $125.42 and $178.87 over the past year. Currently, Wall Street analysts expect the stock to reach $178.14 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $164.18 at the most recent close of the market. An investor can expect a potential return of 8.5% based on the average DGX price forecast.
Analyzing the DGX fundamentals
Quest Diagnostics, Inc [NYSE:DGX] reported sales of 9.87B for the trailing twelve months, which represents a growth of 14.55%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 160.91 points at the first support level, and at 157.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 170.38, and for the 2nd resistance point, it is at 176.57.
Ratios To Look Out For
For context, Quest Diagnostics, Inc’s Current Ratio is 1.10. On the other hand, the Quick Ratio is 1.02, and the Cash Ratio is 0.25. Considering the valuation of this stock, the price to sales ratio is 1.85, the price to book ratio is 2.69 and price to earnings (TTM) ratio is 21.33.
Transactions by insiders
Recent insider trading involved Davis J. E., CEO and President, that happened on Apr 02 ’25 when 39191.0 shares were sold. SVP, Clinical Solutions, KUPPUSAMY KARTHIK completed a deal on Apr 02 ’25 to sell 2555.0 shares. Meanwhile, Officer Davis J. E. bought 39191.0 shares on Apr 02 ’25.
